Necrotizing Fasciitis: Clinical Trials

13 trials for Necrotizing Fasciitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 unknown, 1 active not recruiting, 1 terminated. 2 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Terminated 1
Phase 21Completed 1
Phase 31Completed 1
Phase 41Active not recruiting 1

Follow Necrotizing Fasciitis: new trials by email Literature Review of Necrotizing Fasciitis trials Research Report on Necrotizing Fasciitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF
Acellular Fish Skin Graft (AFS) with Standard of Care Negative Pressure Wound Therapy (NPWT), Acellular Human Cadaver (AHC) with Standard of care Negative Pressure Wound Therapy (NPWT) - Necrotizing Fasciitis
Phase 4Active not recruitingKerecis Ltd.302023-08-012024-12-30
SKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit: a Prospective Multi-national Cohort Study
non interventional - Necrotizing Fasciitis, Fournier Gangrene
UnknownHenri Mondor University Hospital10332021-11-082021-11-23
RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction
Control Intervention (Conventional Autograft), Investigational Intervention (RECELL + more widely meshed autograft) - Full-thickness Skin Defects, Degloving Injuries
Not applicableCompletedAvita Medical652020-03-022024-07-30
Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections
AB103 0.5 mg/kg, NaCl 0.9% - Necrotizing Soft Tissue Infections, Necrotizing Fasciitis
Phase 3CompletedAtox Bio Ltd2902015-12-012021-10-05
Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
IVIG (Privigen), Saline 0.9% - Necrotizing Soft Tissue Infection, Necrotizing Fasciitis
Phase 2CompletedAnders Perner1002014-04-012016-09-30
Severe Soft Tissue Infections: Perspectives of Patients and Significant Others
Necrotizing Fasciitis
UnknownGöteborg University302014-01-012018-08-14
Biomarkers in Patients With Flesh-eating Bacterial Infections
Necrotizing Soft Tissue Infection, Necrotizing Fasciitis
CompletedOle Hyldegaard1692013-02-012016-02-17
Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment
Necrotizing Soft Tissue Infection, Necrotizing Fasciitis
CompletedOle Hyldegaard652013-02-012019-06-24
Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).
Soft Tissue Infections, Necrotizing Fasciitis
CompletedKarolinska Institutet4092013-01-012018-04-23
Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections
Infective Endocarditis, Necrotizing Fasciitis
CompletedUniversitaire Ziekenhuizen KU Leuven892012-07-012023-09-05
Hyperglycemia in Surgical Infections
Strict Glycemic control, Conventional Glycemic Control - Necrotizing Fasciitis
Not applicableTerminatedThe University of Texas Health Science Center, Houston52009-08-012018-11-21
Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features
Necrotizing Fasciitis
CompletedNational Taiwan University Hospital1342009-07-012012-11-15
Outcome and Related Factors of Necrotizing Fasciitis of the Limb
Necrotizing Fasciitis
CompletedTehran University of Medical Sciences252007-09-012009-10-06

Narrower conditions

Fasciitis, Necrotizing (13)  ·  Fournier Gangrene (5)  ·  Gas Gangrene (3)  ·  Soft Tissue Infections (3)  ·  Fasciitis (2)  ·  Infections (2)  ·  Staphylococcal Infections (2)  ·  Bacterial Infections (1)  ·  Cellulitis (1)  ·  Crush Injuries (1)  ·  Degloving Injuries (1)  ·  Disease (1)  ·  Endocarditis (1)  ·  Gangrene (1)  ·  Necrosis (1)

Broader conditions

Musculoskeletal Diseases (13)  ·  Fasciitis (11)  ·  Bacterial Infections and Mycoses (6)  ·  Bacterial Infections (5)  ·  Genital Diseases (5)  ·  Genital Diseases, Male (5)  ·  Infections (5)  ·  Male Urogenital Diseases (5)  ·  Urogenital Diseases (5)  ·  Gram-Positive Bacterial Infections (4)  ·  Clostridium Infections (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Infectious (2)

Interventions

Sodium Chloride (2)  ·  AB103 (1)  ·  Immunoglobulin G (1)  ·  Immunoglobulins, Intravenous (1)  ·  Saline Solution (1)

Sponsors

Ole Hyldegaard (2)  ·  Anders Perner (1)  ·  Atox Bio Ltd (1)  ·  Avita Medical (1)  ·  Göteborg University (1)  ·  Henri Mondor University Hospital (1)  ·  Karolinska Institutet (1)  ·  Kerecis Ltd. (1)  ·  National Taiwan University Hospital (1)  ·  Tehran University of Medical Sciences (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)

Countries

Denmark (5)  ·  United States (4)  ·  France (2)  ·  Sweden (2)  ·  Belgium (1)  ·  Iran (1)  ·  Norway (1)  ·  Taiwan (1)

Top investigators

Marco Bo Hansen, MD (2)  ·  Ole Hyldegaard, MD, PhD (2)  ·  Anders Perner, Professor (1)  ·  Bounthavy Homsombath, MD (1)  ·  Chi-Tai Fang, MD, PhD (1)  ·  Eileen M Bulger, MD (1)  ·  Lillian S Kao, MD (1)  ·  Nicolas de Prost, MD, PhD (1)  ·  Peter Verhamme, MD,PhD (1)  ·  Ramin Espandar, MD (1)  ·  Wayne M Dankner, MD (1)

Results publications

PMID 31916575, PMID 25967993, PMID 26880104, PMID 27399982, PMID 28421246, PMID 32082310, PMID 32657946, PMID 34263738, PMID 36427229, PMID 37946314, PMID 38098145, PMID 39810178, PMID 40613866

NIH funding

K23RR020020 (1)